Skip to main content
. 2020 May 27;24(9):829–835. doi: 10.1007/s10157-020-01904-w

Table 1.

Demographic and clinical characteristics of the patients at baseline

Characteristics Total (N = 32) Diabetes (N = 16) Non-diabetes (N = 16) P value
Dialysis vintage, median (range)-month 33.5 (1–170) 29.5 (3–125) 39 (1–170) 0.256
Male sex-no., % 0.694
 Male 23 (71.9%) 12 (75.0%) 11 (68.8%)
Age, median (range)-years 58.5 (36–83) 64.5 (41–83) 56.5 (36–77) 0.059
Age groups-no., % 0.072
 30–60 years old 19 (59.4%) 7 (43.8%) 12 (75.0%)
 ≥ 61 years old 13 (40.6%) 9 (56.2%) 4 (25.0%)
Kidney transplant-no., % 2 (6.25%) 0 (0.0%) 2 (12.5%) 0.144
Hypertension-no., % 32 (100%) 16 (100%) 16 (100%) 1
Use of ARB Antihypertensive drugs-no., % 11 (34.375%) 4 (25.0%) 7 (43.8%) 0.264
Use of ACEI antihypertensive drugs-no., % 15 (46.875%) 6 (37.5%) 9 (56.2%) 0.288
Huanan seafood wholesale market exposure-no., % 2 (6.25%) 2 (12.5%) 0 (0.0%) 0.144
Signs and symptoms at admission
 Asymptomatic 2 (6.25%) 2 (12.5%) 0 0.088
 Fever 15 (46.875%) 6 (37.5%) 9 (56.25%) 0.286
 Cough 21 (65.625%) 11 (68.75%) 10 (62.5%) 0.71
 Gasping 2 (6.25%) 1 (6.25%) 1 (6.25) 1
 Fatigue 7 (21.875%) 3 (18.75%) 4 (25%) 0.669
 Inappetence 3 (9.375%) 1 (6.25%) 2 (12.5%) 0.541
 Vomit 1 (3.125%) 0 1 (6.25%) 0.234
 Diarrhea 3 (9.375%) 2 (12.5%) 1 (6.25%) 0.541
 Nausea 3 (9.375%) 2 (12.5%) 1 (6.25%) 0.541
 Muscular soreness 2 (6.25%) 1 (6.25%) 1 (6.25) 1

ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker